3 Asian Stocks Estimated To Be Trading At Up To 21.8% Below Intrinsic Value

Amidst global economic fluctuations and geopolitical tensions, Asian markets have been navigating a complex landscape marked by mixed signals from trade data and inflationary pressures. As investors seek opportunities within this environment, identifying undervalued stocks becomes crucial, especially those trading below their intrinsic value, offering potential for growth despite prevailing uncertainties.

Top 10 Undervalued Stocks Based On Cash Flows In Asia

Name	Current Price	Fair Value (Est)	Discount (Est)
TRIAL Holdings (TSE:141A)	¥2789.00	¥5491.20	49.2%
Strike Group (TSE:6196)	¥1262.00	¥2447.05	48.4%
Precision Tsugami (China) (SEHK:1651)	HK$52.45	HK$103.96	49.5%
Pegasus (TSE:6262)	¥512.00	¥1008.12	49.2%
Moshi Moshi Retail Corporation (SET:MOSHI)	THB36.75	THB71.34	48.5%
Innovent Biologics (SEHK:1801)	HK$76.45	HK$152.88	50%
Cybozu (TSE:4776)	¥2293.00	¥4513.60	49.2%
China XLX Fertiliser (SEHK:1866)	HK$10.11	HK$20.17	49.9%
APR (KOSE:A278470)	₩394000.00	₩769987.44	48.8%
Alltop Technology (TPEX:3526)	NT$323.00	NT$629.99	48.7%

Click here to see the full list of 176 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Here's a peek at a few of the choices from the screener.

ALTEOGEN (KOSDAQ:A196170)

Overview: ALTEOGEN Inc. is a biotechnology company specializing in the development of long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩18.05 trillion.

Operations: The company's revenue is derived from its biotechnology segment, amounting to ₩203.76 million.

Estimated Discount To Fair Value: 10.4%

Alteogen is trading at ₩337,000, slightly below its estimated future cash flow value of ₩376,010.27. Recent strategic alliances, such as the exclusive license agreement with Biogen for ALT-B4 technology, bolster its growth prospects. Preclinical data presented at the World ADC Summit highlights improved drug absorption and safety profiles using ALT-B4 in subcutaneous formulations. Earnings and revenue are forecast to grow significantly faster than the Korean market averages over the next three years.

• In light of our recent growth report, it seems possible that ALTEOGEN's financial performance will exceed current levels.
• Take a closer look at ALTEOGEN's balance sheet health here in our report.

COSCO SHIPPING Energy Transportation (SEHK:1138)

Overview: COSCO SHIPPING Energy Transportation Co., Ltd. is an investment holding company involved in the transportation of oil and liquefied natural gas (LNG) both within the People's Republic of China and internationally, with a market cap of approximately HK$102.93 billion.

Operations: COSCO SHIPPING Energy Transportation Co., Ltd. generates revenue through its operations in the transportation of oil and liquefied natural gas (LNG) across domestic and international markets.

Estimated Discount To Fair Value: 20.5%

COSCO SHIPPING Energy Transportation is trading at HK$14.23, below its estimated future cash flow value of HK$17.9, suggesting undervaluation. The company's earnings grew 57.1% last year and are forecast to grow significantly at 26.9% annually over the next three years, outpacing the Hong Kong market's average growth rate. However, despite strong revenue growth and a proposed dividend increase, its dividend yield of 3.09% isn't well-supported by free cash flows.

• Our growth report here indicates COSCO SHIPPING Energy Transportation may be poised for an improving outlook.
• Dive into the specifics of COSCO SHIPPING Energy Transportation here with our thorough financial health report.

Kotobuki Spirits (TSE:2222)

Overview: Kotobuki Spirits Co., Ltd. produces and sells sweets both in Japan and internationally, with a market cap of ¥361.76 billion.

Operations: Kotobuki Spirits generates revenue from its production and sale of sweets in both domestic and international markets.

Estimated Discount To Fair Value: 21.8%

Kotobuki Spirits, priced at ¥2342.5, is trading below its estimated future cash flow value of ¥2994.45, highlighting potential undervaluation. The company's earnings are expected to grow annually by 10.6%, surpassing the Japanese market's average growth rate. Recent board decisions focus on flexible capital and dividend policies, potentially impacting future cash flow distribution positively. Revenue for the fiscal year ending March 2026 is projected to rise by 8.9% to ¥78.80 billion from the previous year.

• According our earnings growth report, there's an indication that Kotobuki Spirits might be ready to expand.
• Get an in-depth perspective on Kotobuki Spirits' balance sheet by reading our health report here.

Where To Now?

• Click this link to deep-dive into the 176 companies within our Undervalued Asian Stocks Based On Cash Flows screener.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com